SofWave Medical Ltd. (TLV:SOFW)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
3,999.00
-42.00 (-1.04%)
At close: Mar 19, 2026
Market Cap1.44B +146.0%
Revenue (ttm)255.13M +36.1%
Net Income2.26M
EPS0.06
Shares Out36.11M
PE Ratio637.63
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume70,603
Average Volume69,659
Open4,041.00
Previous Close4,041.00
Day's Range3,900.00 - 4,050.00
52-Week Range1,300.00 - 4,104.00
Beta0.82
RSI69.20
Earnings DateMar 17, 2026

About SofWave Medical

SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin rejuvenation and firming treatments in Israel and internationally. The company offers an ultrasound technology, which induces coagulation and subsequent revitalization under the SUPERB brand name; and non-invasive muscle toning technology under the Pure Impact brand. It serves plastic surgeons, dermatologists, and other physicians who perform aesthetic treatments on patients. The company was incorporated in 2015 a... [Read more]

Sector Healthcare
Founded 2015
Employees 126
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol SOFW
Full Company Profile

Financial Performance

In 2024, SofWave Medical's revenue was $59.65 million, an increase of 18.56% compared to the previous year's $50.32 million. Losses were -$4.55 million, -45.08% less than in 2023.

Financial numbers in USD Financial Statements